Internet Archive Scholar

MSJ808189_supplementary_tables – Supplemental material for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch, Gavin Giovannoni
2018 Figshare  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (660.3 kB)
https://web.archive.org/web/20200227230046/https://s3-eu-west-1.amazonaws.com/pstorage-sage-1076303800/13569653/MSJ808189_supplementary_tables.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Supplemental material, MSJ808189_supplementary_tables for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial by Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch and Gavin Giovannoni in Multiple Sclerosis Journal
doi:10.25384/sage.7343696 fatcat:h7bleeehkrb5vl6y7xbdcn7bsq
Open Access
Citation

Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch, Gavin Giovannoni. "MSJ808189_supplementary_tables – Supplemental material for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial." Figshare (2018)